BioNTech IMFS develops and manufactures retroviral vectors, cell-based therapy products, and GMP grade IVT mRNA. The company provides process development, assay development, GMP manufacturing, and quality control services.

BioNTech IMFS

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Apple Mobile Web Clips Icon

HSTS

Apache

Apple Mobile Web App Capable

Apple Mobile Web App Status Bar Style

GlobalSign

TYPO3

Operations

Christoph Weigand

Project Manager

Christina Harprecht

Head of Cell Therapy, Manufacturing

Iris Bigalke

QA-Manager

Maximilian Schöne

Engineering

Adrian Flierl

Marketing and Product

Erik Van Leeuwen

Gladynel Baez

Rheinland-Pfalz Companies With More Than $10M in Revenue

Germany Companies With Less Than $500M in Revenue (Top 10K)

Biotechnology Companies With More Than 50 Employees

European Union (EU) Therapeutics Companies

BioNTech IMFS is a contract development and manufacturing organization of cell and gene therapy products.

Idar-oberstein

Rheinland-Pfalz

Germany

Europe

Singapore

Asia

Italy

Serbia

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:06 PM	fbfdeae8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:06 PM	79a9463d
crunchbase trigger	general	Nov 22, 2024 7:44 AM	f469d622
crunchbase profile	general	Nov 22, 2024 10:18 AM	744be530
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 2:19 PM	564b861c
peers	general	Sep 27, 2024 4:06 PM	9080f7a4
news basic	general	Sep 27, 2024 4:06 PM	a52773c7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

DE:BIONTECH-IMFS

BioNTech IMFS